Yuviflox-M Oral Suspension Mango is a combination antibiotic formulation containing Ofloxacin (50mg/5ml), Metronidazole (120mg/5ml), and Simethicone (10mg/5ml), designed for the treatment of mixed bacterial and protozoal infections accompanied by gastrointestinal discomfort. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication. Metronidazole, an antiprotozoal and antibacterial agent, is effective against anaerobic bacteria and protozoa by causing DNA strand breakage and inhibiting nucleic acid synthesis. Simethicone acts as an anti-foaming agent, reducing bloating and discomfort by facilitating the coalescence and expulsion of gas bubbles in the gastrointestinal tract. This oral suspension, flavored with mango for improved palatability, is indicated for the treatment of gastrointestinal infections such as amoebiasis, giardiasis, bacterial diarrhea, and mixed infections where anaerobic and aerobic pathogens coexist. The combination therapy ensures a broad antimicrobial spectrum, while simethicone provides symptomatic relief from gas-related symptoms. Yuviflox-M Oral Suspension should be used under medical supervision with appropriate dosing adjustments based on patient age, weight, and clinical condition. Caution is advised in patients with hypersensitivity to fluoroquinolones, metronidazole, or simethicone.